Tumor slice culture system for ex vivo immunotherapy studies.

Methods Cell Biol

Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. Electronic address:

Published: October 2024

AI Article Synopsis

Article Abstract

Personalized immunotherapy is emerging as a promising approach for cancer treatment, aiming to harness the patient's own immune system to target and eliminate tumor cells. One key aspect of developing effective personalized immunotherapies is the utilization of tumor slices derived from individual patient tumors. Tumor slice models retain the complexity and heterogeneity of the original tumor microenvironment, including interactions with immune cells, stromal elements, and vasculature. These ex vivo models serve as valuable tools for studying tumor-immune interactions and for testing the efficacy of immunotherapeutic agents tailored to the specific characteristics of each patient's tumor. In this chapter, we set up a protocol for immunotherapy strategies in mouse models highlighting their translational potential to guide treatment decisions and improve therapeutic outcomes in cancer patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.mcb.2024.05.007DOI Listing

Publication Analysis

Top Keywords

tumor slice
8
tumor
6
slice culture
4
culture system
4
system vivo
4
vivo immunotherapy
4
immunotherapy studies
4
studies personalized
4
personalized immunotherapy
4
immunotherapy emerging
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!